CORVUS PHARMACEUTICALS INC. - COMMON STOCK
9.1800
25-11月-24 11:38:46
15 分の遅延
株式
+0.2300
+2.57%
本日の幅
8.9550 - 9.3529
ISIN
N/A
ソース
NASDAQ
-
Corvus Pharmaceuticals Announces IND Acceptance for Phase 1/1b Clinical Trial of CPI-818 in China
16 8 2021 16:00:00 提供 Nasdaq GlobeNewswire
-
Corvus Pharmaceuticals Provides Business Update and Reports Second Quarter 2021 Financial Results
02 8 2021 15:05:01 提供 Nasdaq GlobeNewswire
-
15 7 2021 15:05:00 提供 Nasdaq GlobeNewswire
-
Corvus Pharmaceuticals to Present at the Jefferies Virtual Healthcare Conference
25 5 2021 15:05:00 提供 Nasdaq GlobeNewswire
-
Corvus Pharmaceuticals Completes Sale of $10 Million Through Its ATM Program
05 5 2021 08:00:01 提供 Nasdaq GlobeNewswire
-
Corvus Pharmaceuticals Provides Business Update and Reports First Quarter 2021 Financial Results
29 4 2021 15:05:01 提供 Nasdaq GlobeNewswire
-
25 3 2021 07:30:00 提供 Nasdaq GlobeNewswire
-
Corvus Pharmaceuticals Announces Participation in Upcoming Investor Conferences
05 3 2021 07:30:00 提供 Nasdaq GlobeNewswire
-
Corvus Pharmaceuticals Announces Closing of Public Offering of Common Stock
17 2 2021 15:10:00 提供 Nasdaq GlobeNewswire
-
Corvus Pharmaceuticals Announces Pricing of Public Offering of Common Stock
12 2 2021 08:00:00 提供 Nasdaq GlobeNewswire
-
Corvus Pharmaceuticals Announces Proposed Public Offering of Common Stock
11 2 2021 15:01:00 提供 Nasdaq GlobeNewswire
-
Corvus Pharmaceuticals Initiates Phase 3 Clinical Trial of CPI-006 for Patients with COVID-19
04 2 2021 06:30:00 提供 Nasdaq GlobeNewswire